FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004384106> ?p ?o ?g. }

• W2004384106 endingPage "635" @default.
• W2004384106 startingPage "625" @default.
• W2004384106 abstract "Coeliac disease (CD) is a malabsorptive enteropathy resulting from intolerance to gluten. Environmental factors and the microbiota are suggested to have critical roles in the onset of CD. The CD71 IgA receptor on epithelial cells is responsible for abnormal retrotranscytosis of IgA-gluten peptide complexes from the intestinal lumen into the lamina propria, inducing intestinal inflammation. However, understanding the role of gluten in the CD physiopathology has been hindered by the absence of relevant animal models. Here, we generated a mouse model for CD to study the factors controlling its pathogenesis as well as to investigate the influence of oral delivery of probiotics on disease development. Gluten sensitivity was established by feeding three generations of BALB/c mice a gluten-free diet (G-) followed by gluten challenge (G+) for 30 days. The G+ mice developed villous atrophy, crypt hyperplasia and infiltration of T cells and macrophages in the small intestine. Inflammation was associated with an overexpression of CD71 on the apical side of enterocytes and an increase of plasma cells producing IgA, which colocalised with the CD71. Moreover, IgA colocalised with the transglutaminase 2 (TG2), the production of which was increased in the lamina propria of G+ mice. These mice displayed increased production of cyclooxygenase-2 (COX-2), pro-inflammatory cytokines and IL-15, as well as anti-gliadin and anti-TG2 autoantibodies. The commensal flora-isolated presumptive probiotic Saccharomyces boulardii KK1 strain hydrolysed the 28-kDa α-gliadin fraction, and its oral delivery in G+ mice improved enteropathy development in association with decrease of epithelial cell CD71 expression and local cytokine production. In conclusion, the G+ BALB/c mouse represents a new mouse model for human CD based on histopathological features and expression of common biomarkers. The selected probiotic treatment reversing disease development will allow the study of the role of probiotics as a new therapeutic approach of CD." @default.
• W2004384106 created "2016-06-24" @default.
• W2004384106 creator A5015989139 @default.
• W2004384106 creator A5025993462 @default.
• W2004384106 creator A5030421314 @default.
• W2004384106 creator A5051266819 @default.
• W2004384106 creator A5053769000 @default.
• W2004384106 creator A5059903212 @default.
• W2004384106 creator A5060948125 @default.
• W2004384106 creator A5072928493 @default.
• W2004384106 creator A5076075315 @default.
• W2004384106 date "2012-04-01" @default.
• W2004384106 modified "2023-10-10" @default.
• W2004384106 title "Gluten induces coeliac-like disease in sensitised mice involving IgA, CD71 and transglutaminase 2 interactions that are prevented by probiotics" @default.
• W2004384106 cites W1505412867 @default.
• W2004384106 cites W1971348565 @default.
• W2004384106 cites W1972218561 @default.
• W2004384106 cites W1972919397 @default.
• W2004384106 cites W1991329887 @default.
• W2004384106 cites W1991473719 @default.
• W2004384106 cites W2004575036 @default.
• W2004384106 cites W2004776622 @default.
• W2004384106 cites W2021158198 @default.
• W2004384106 cites W2026372461 @default.
• W2004384106 cites W2038884625 @default.
• W2004384106 cites W2043856196 @default.
• W2004384106 cites W2050924395 @default.
• W2004384106 cites W2053580563 @default.
• W2004384106 cites W2059530038 @default.
• W2004384106 cites W2059761425 @default.
• W2004384106 cites W2078710292 @default.
• W2004384106 cites W2089830568 @default.
• W2004384106 cites W2105758599 @default.
• W2004384106 cites W2112155625 @default.
• W2004384106 cites W2116673726 @default.
• W2004384106 cites W2131132948 @default.
• W2004384106 cites W2154801271 @default.
• W2004384106 cites W2161266638 @default.
• W2004384106 cites W2319067283 @default.
• W2004384106 cites W2091442445 @default.
• W2004384106 doi "https://doi.org/10.1038/labinvest.2012.13" @default.
• W2004384106 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22330344" @default.
• W2004384106 hasPublicationYear "2012" @default.
• W2004384106 type Work @default.
• W2004384106 sameAs 2004384106 @default.
• W2004384106 citedByCount "62" @default.
• W2004384106 countsByYear W20043841062012 @default.
• W2004384106 countsByYear W20043841062013 @default.
• W2004384106 countsByYear W20043841062014 @default.
• W2004384106 countsByYear W20043841062015 @default.
• W2004384106 countsByYear W20043841062016 @default.
• W2004384106 countsByYear W20043841062017 @default.
• W2004384106 countsByYear W20043841062018 @default.
• W2004384106 countsByYear W20043841062019 @default.
• W2004384106 countsByYear W20043841062020 @default.
• W2004384106 countsByYear W20043841062021 @default.
• W2004384106 countsByYear W20043841062022 @default.
• W2004384106 countsByYear W20043841062023 @default.
• W2004384106 crossrefType "journal-article" @default.
• W2004384106 hasAuthorship W2004384106A5015989139 @default.
• W2004384106 hasAuthorship W2004384106A5025993462 @default.
• W2004384106 hasAuthorship W2004384106A5030421314 @default.
• W2004384106 hasAuthorship W2004384106A5051266819 @default.
• W2004384106 hasAuthorship W2004384106A5053769000 @default.
• W2004384106 hasAuthorship W2004384106A5059903212 @default.
• W2004384106 hasAuthorship W2004384106A5060948125 @default.
• W2004384106 hasAuthorship W2004384106A5072928493 @default.
• W2004384106 hasAuthorship W2004384106A5076075315 @default.
• W2004384106 hasBestOaLocation W20043841061 @default.
• W2004384106 hasConcept C126322002 @default.
• W2004384106 hasConcept C134018914 @default.
• W2004384106 hasConcept C178498320 @default.
• W2004384106 hasConcept C181199279 @default.
• W2004384106 hasConcept C203014093 @default.
• W2004384106 hasConcept C22814914 @default.
• W2004384106 hasConcept C2776336767 @default.
• W2004384106 hasConcept C2776914184 @default.
• W2004384106 hasConcept C2777310793 @default.
• W2004384106 hasConcept C2778426112 @default.
• W2004384106 hasConcept C2779134260 @default.
• W2004384106 hasConcept C2780092158 @default.
• W2004384106 hasConcept C2780349322 @default.
• W2004384106 hasConcept C32264632 @default.
• W2004384106 hasConcept C529295009 @default.
• W2004384106 hasConcept C54355233 @default.
• W2004384106 hasConcept C55493867 @default.
• W2004384106 hasConcept C71924100 @default.
• W2004384106 hasConcept C86803240 @default.
• W2004384106 hasConceptScore W2004384106C126322002 @default.
• W2004384106 hasConceptScore W2004384106C134018914 @default.
• W2004384106 hasConceptScore W2004384106C178498320 @default.
• W2004384106 hasConceptScore W2004384106C181199279 @default.
• W2004384106 hasConceptScore W2004384106C203014093 @default.
• W2004384106 hasConceptScore W2004384106C22814914 @default.
• W2004384106 hasConceptScore W2004384106C2776336767 @default.
• W2004384106 hasConceptScore W2004384106C2776914184 @default.
• W2004384106 hasConceptScore W2004384106C2777310793 @default.
• W2004384106 hasConceptScore W2004384106C2778426112 @default.

• next